John Sundy, Chief Medical Officer at Pandion Therapeutics, Inc. (PAND), bought 2,000 shares at $18.00 ($36K) on 2020-07-21, disclosed to the SEC on 2020-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.